414 related articles for article (PubMed ID: 19050039)
1. Dominant-negative inhibition of Ca2+ influx via TRPV2 ameliorates muscular dystrophy in animal models.
Iwata Y; Katanosaka Y; Arai Y; Shigekawa M; Wakabayashi S
Hum Mol Genet; 2009 Mar; 18(5):824-34. PubMed ID: 19050039
[TBL] [Abstract][Full Text] [Related]
2. A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor-regulated channel.
Iwata Y; Katanosaka Y; Arai Y; Komamura K; Miyatake K; Shigekawa M
J Cell Biol; 2003 Jun; 161(5):957-67. PubMed ID: 12796481
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of Ca2+ handling drugs against abnormal Ca2+ homeostasis and cell damage in myopathic skeletal muscle cells.
Iwata Y; Katanosaka Y; Shijun Z; Kobayashi Y; Hanada H; Shigekawa M; Wakabayashi S
Biochem Pharmacol; 2005 Sep; 70(5):740-51. PubMed ID: 16009351
[TBL] [Abstract][Full Text] [Related]
4. Mechanosensitive ion channels in skeletal muscle: a link in the membrane pathology of muscular dystrophy.
Lansman JB; Franco-Obregón A
Clin Exp Pharmacol Physiol; 2006 Jul; 33(7):649-56. PubMed ID: 16789935
[TBL] [Abstract][Full Text] [Related]
5. Targeted inhibition of Ca2+ /calmodulin signaling exacerbates the dystrophic phenotype in mdx mouse muscle.
Chakkalakal JV; Michel SA; Chin ER; Michel RN; Jasmin BJ
Hum Mol Genet; 2006 May; 15(9):1423-35. PubMed ID: 16551657
[TBL] [Abstract][Full Text] [Related]
6. Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species.
Whitehead NP; Yeung EW; Allen DG
Clin Exp Pharmacol Physiol; 2006 Jul; 33(7):657-62. PubMed ID: 16789936
[TBL] [Abstract][Full Text] [Related]
7. Ca(2+) influx and opening of Ca(2+)-activated K(+) channels in muscle fibers from control and mdx mice.
Mallouk N; Allard B
Biophys J; 2002 Jun; 82(6):3012-21. PubMed ID: 12023224
[TBL] [Abstract][Full Text] [Related]
8. Drastic reduction of sarcalumenin in Dp427 (dystrophin of 427 kDa)-deficient fibres indicates that abnormal calcium handling plays a key role in muscular dystrophy.
Dowling P; Doran P; Ohlendieck K
Biochem J; 2004 Apr; 379(Pt 2):479-88. PubMed ID: 14678011
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Ca²⁺ influx from STIM1-Orai1 induces muscle pathology in mouse models of muscular dystrophy.
Goonasekera SA; Davis J; Kwong JQ; Accornero F; Wei-LaPierre L; Sargent MA; Dirksen RT; Molkentin JD
Hum Mol Genet; 2014 Jul; 23(14):3706-15. PubMed ID: 24556214
[TBL] [Abstract][Full Text] [Related]
10. Dystrophic cardiomyopathy: role of TRPV2 channels in stretch-induced cell damage.
Lorin C; Vögeli I; Niggli E
Cardiovasc Res; 2015 Apr; 106(1):153-62. PubMed ID: 25616416
[TBL] [Abstract][Full Text] [Related]
11. Production of TRPV2-targeting functional antibody ameliorating dilated cardiomyopathy and muscular dystrophy in animal models.
Iwata Y; Wakabayashi S; Ito S; Kitakaze M
Lab Invest; 2020 Feb; 100(2):324-337. PubMed ID: 31896817
[TBL] [Abstract][Full Text] [Related]
12. TRPV2 is a component of osmotically sensitive cation channels in murine aortic myocytes.
Muraki K; Iwata Y; Katanosaka Y; Ito T; Ohya S; Shigekawa M; Imaizumi Y
Circ Res; 2003 Oct; 93(9):829-38. PubMed ID: 14512441
[TBL] [Abstract][Full Text] [Related]
13. Translocation of calcium-permeable TRPV2 channel to the podosome: Its role in the regulation of podosome assembly.
Nagasawa M; Kojima I
Cell Calcium; 2012 Feb; 51(2):186-93. PubMed ID: 22226146
[TBL] [Abstract][Full Text] [Related]
14. Transient receptor potential cation channels in normal and dystrophic mdx muscle.
Krüger J; Kunert-Keil C; Bisping F; Brinkmeier H
Neuromuscul Disord; 2008 Jun; 18(6):501-13. PubMed ID: 18504127
[TBL] [Abstract][Full Text] [Related]
15. Dystrophic cardiomyopathy: amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathways.
Jung C; Martins AS; Niggli E; Shirokova N
Cardiovasc Res; 2008 Mar; 77(4):766-73. PubMed ID: 18056762
[TBL] [Abstract][Full Text] [Related]
16. A canine minidystrophin is functional and therapeutic in mdx mice.
Wang B; Li J; Qiao C; Chen C; Hu P; Zhu X; Zhou L; Bogan J; Kornegay J; Xiao X
Gene Ther; 2008 Aug; 15(15):1099-106. PubMed ID: 18432277
[TBL] [Abstract][Full Text] [Related]
17. Characterization of ARC, apoptosis repressor interacting with CARD, in normal and dystrophin-deficient skeletal muscle.
Abmayr S; Crawford RW; Chamberlain JS
Hum Mol Genet; 2004 Jan; 13(2):213-21. PubMed ID: 14645204
[TBL] [Abstract][Full Text] [Related]
18. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice.
Nakatani M; Takehara Y; Sugino H; Matsumoto M; Hashimoto O; Hasegawa Y; Murakami T; Uezumi A; Takeda S; Noji S; Sunada Y; Tsuchida K
FASEB J; 2008 Feb; 22(2):477-87. PubMed ID: 17893249
[TBL] [Abstract][Full Text] [Related]
19. Effect of calpain and proteasome inhibition on Ca2+-dependent proteolysis and muscle histopathology in the mdx mouse.
Briguet A; Erb M; Courdier-Fruh I; Barzaghi P; Santos G; Herzner H; Lescop C; Siendt H; Henneboehle M; Weyermann P; Magyar JP; Dubach-Powell J; Metz G; Meier T
FASEB J; 2008 Dec; 22(12):4190-200. PubMed ID: 18728218
[TBL] [Abstract][Full Text] [Related]
20. Diltiazem and verapamil protect dystrophin-deficient muscle fibers of MDX mice from degeneration: a potential role in calcium buffering and sarcolemmal stability.
Matsumura CY; Pertille A; Albuquerque TC; Santo Neto H; Marques MJ
Muscle Nerve; 2009 Feb; 39(2):167-76. PubMed ID: 19145649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
